Navigation Links
Clinical Study With Investigational Cream Aims To Help Women Who Experience Painful Sex
Date:9/4/2012

NEW YORK, Sept. 4, 2012 /PRNewswire/ -- NeoGyn Vulvar Soothing Cream is sponsoring a clinical study held in four medical centers throughout the United States to test the effectiveness of an investigational cream.

(Photo: http://photos.prnewswire.com/prnh/20120717/NY41829 )

The study is being conducted at The Centers for Vulvovaginal Disorders in Washington DC, Pelvic & Sexual Health Institute in Philadelphia, PA, San Diego Sexual Medicine in San Diego, CA and Arizona Vulva Clinic. Additional applicants are needed for each location to participate in the randomized, double- blind, placebo controlled Research Study to evaluate a vulvar soothing cream containing cutaneous lysate for vulvar use.

Provoked vestibulodynia is classified as spontaneous pain in the vulvar region. The condition is typically characterized by pain at the entry point into the vagina during tampon insertion or sexual intercourse. Causes of provoked vestibulodynia can vary, which contributes to making it difficult for doctors to diagnose and treat this condition.

Each three month study will be led by physicians specialized in the field of women's health and vulvar care including, Dr. Andrew Goldstein, MD, Dr. Kristene Whitmore, MD and Dr. Susan Kellogg PhD, Dr. Irwin Goldstein, MD, and Dr. Joseph Brooks, MD. After inclusion, participants will attend one follow-up clinic visit, two telephone interviews and complete several questionnaires over the course of the study. The study cream and other study related tests, procedures and visits will be provided at no cost to each selected participant.

Eligible applicants are women who live in close proximity to the study sites and are 20-55 years old. Participants cannot be pregnant or breast-feeding and should be in a heterosexual relationship where a reliable form of birth control is being used. Pain experienced with the use of tampons or f
'/>"/>

SOURCE NeoGyn
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
2. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
3. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
4. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
5. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
8. First Patient Treated in U.S. Clinical Study of Cohera Medicals TissuGlu® Surgical Adhesive
9. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 Ardelyx, Inc. (NASDAQ: ... gastrointestinal and cardio-renal diseases, today announced that Sanofi ... and license agreement for Ardelyx,s portfolio of NaP2b ... payment associated with termination and the return of ... Sanofi entered into an option and license agreement ...
(Date:9/1/2015)... Sept. 1, 2015  Dynatronics Corporation (NASDAQ: ... at the First Annual Ladenburg Thalmann Healthcare Conference ... Kelvyn H. Cullimore, Jr. , Chairman and ... investment representatives on Tuesday, September 29 at 10:30 ... Conference will showcase leading-edge companies in the healthcare ...
(Date:9/1/2015)... -- Dr. Cindy Orser , the Chief Science Officer ... of DigiPath, Inc. (OTCQB: DIGP), was recently interviewed ... consistency in today,s medical cannabis testing industry. In her ... she explained that the state-to-state variations in cannabis laws ... makes standardization impossible. Dr. Orser is ...
Breaking Medicine Technology:Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3
... China , April 29 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, Inc. (NYSE ... pharmaceuticals company in China , today announced,that it has retained CCG ... , , ... to working with CCG to establish more effective and,transparent communications channels with ...
... , April 29 Royal Philips Electronics ( ... provider of integration solutions in healthcare, to deploy the Orion Health Rhapsody® ... , , ... , , ...
Cached Medicine Technology:China Pharma Holdings, Inc. Retains CCG Investor Relations 2China Pharma Holdings, Inc. Retains CCG Investor Relations 3China Pharma Holdings, Inc. Retains CCG Investor Relations 4China Pharma Holdings, Inc. Retains CCG Investor Relations 5Philips and Orion Health Partner to Deliver on Enterprise Interoperability 2Philips and Orion Health Partner to Deliver on Enterprise Interoperability 3Philips and Orion Health Partner to Deliver on Enterprise Interoperability 4
(Date:9/1/2015)... ... 02, 2015 , ... The Journal of Pain Research has published ... ”. , As corresponding author Mr Christopher Malone says “Migraine headache is a painful ... endeavoured to better understand how migraine headaches impact the lives of migraineurs. We asked ...
(Date:9/1/2015)... ... 01, 2015 , ... Stress comes in many different forms ... changes can lead to very serious, life-altering events. Fortunately nature offers a range ... supplement manufacturer MediHerb has coupled therapeutic doses of Rhodiola and Schisandra ...
(Date:9/1/2015)... ... September 01, 2015 , ... Georgia State ... universities across the country in stemming sexual assaults on their campuses. , The ... a consortium of sexual assault researchers and student affairs professionals responding to calls ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... vacuum that creates negative pressure inside a wound to remove exudates, fluid, and ... treatment devices (comprising portable devices, stand-alone devices, disposable devices, and canisters, etc.) is ...
(Date:9/1/2015)... PA (PRWEB) , ... September 01, 2015 , ... The ... 18 at The ACE Club and Green Valley Country Club in Lafayette Hill, PA. ... has raised more than $13.5 million for programs and services designed to support patients ...
Breaking Medicine News(10 mins):Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Georgia State, Partners Introduce Climate Survey to Aid in Preventing Campus Sexual Assaults 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3
... It prevents many complications of chronic disease, experts ... who strictly control their blood sugar levels also ... disease, British researchers report. , There have been ... reducing blood sugar levels in diabetic patients in ...
... (Pink Sheets: FTER), owner and operator of the "A ... today that the documentary "Intervention," which features this Forterus ... Network at 7 p.m. Eastern and Pacific on Monday, ... people who are seeking a route to redemption from ...
... Gerberding, former Director of the Center for Disease Control and Prevention ... and of CAI International Inc., have been elected to the ... ... Washington, D.C. (Vocus) May 22, 2009 -- Dr. Julie Gerberding, ...
... African American women with late stage breast cancer refused chemotherapy ... July 1, 2009 issue of CANCER , a peer-reviewed ... more efforts are needed to ensure that all women with ... African American women have almost twice the rate of advanced ...
... can be linked to different invasive breast cancer subtypes. ... open access journal Breast Cancer Research , suggests ... are associated with different kinds of tumor. , Marilyn ... a team of researchers who used data from the ...
... Delivery of PMTCTGENEVA, May 21 In a dramatic ... of the International Treatment Preparedness Coalition (ITPC) and AIDS-Free ... members of UNAIDS and WHO to present ITPC,s latest ... Failing Children: HIV, Vertical Transmission and Women,s Health, ...
Cached Medicine News:Health News:Strict Blood Sugar Control Lowers Heart Risks in Diabetics 2Health News:Strict Blood Sugar Control Lowers Heart Risks in Diabetics 3Health News:Julie Gerberding and Hiromitsu Ogawa Join Accordia Board 2Health News:African-American women with advanced breast cancer often forego vital treatment 2Health News:AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns 2Health News:AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns 3
The Rheumatoid Factor (RF) assay is used for the quantitative analysis of rheumatoid factor in human serum....
Rheumatoid Factor , R1: 4 X 20 ml buffer, R2: 2 X 8 ml antibody, Test / Kit: 320 (H717)...
EXTEND is an absorbable synthetic punctal implant that provides occlusion up to three months. It is packaged 20 implants per box in sizes of .0.3mm, 0.4mm, 0.5mm. A variety pack in also available w...
... The Carriazo-Pendular microkeratome is based ... of the cornea during the cut., ... applanated evenly from the beginning of ... ensures that the intraocular pressure does ...
Medicine Products: